{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:46Z","timestamp":1761919786822,"version":"3.40.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11926-013-0397-0","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T18:00:07Z","timestamp":1387562407000},"source":"Crossref","is-referenced-by-count":22,"title":["Renal Involvement in Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"16","author":[{"given":"Guillermo J.","family":"Pons-Estel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"397_CR1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","volume":"287","author":"GR Hughes","year":"1983","unstructured":"\u2022 Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed). 1983;287:1088\u20139. Original description of antiphospholipid syndrome.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"397_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar2536","volume":"10","author":"G Espinosa","year":"2008","unstructured":"Espinosa G, Cervera R. Antiphospholipid syndrome. Arthritis Res Ther. 2008;10:230.","journal-title":"Arthritis Res Ther"},{"key":"397_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2011.04.011","volume":"10","author":"C Alessandri","year":"2011","unstructured":"Alessandri C, Conti F, Pendolino M, et al. New autoantigens in the antiphospholipid syndrome. Autoimmun Rev. 2011;10:609\u201316.","journal-title":"Autoimmun Rev"},{"key":"397_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"\u2022 Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295\u2013306. Classification criteria of antiphospholipid syndrome.","journal-title":"J Thromb Haemost"},{"key":"397_CR5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1309\/JAMH-GDQ6-6BYK-DW6J","volume":"118","author":"EJ Favaloro","year":"2002","unstructured":"Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol. 2002;118:548\u201357.","journal-title":"Am J Clin Pathol"},{"key":"397_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0037-1613156","volume":"88","author":"G Reber","year":"2002","unstructured":"Reber G, Schousboe I, Tincani A, et al. Inter-laboratory variability of anti-beta2- glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost. 2002;88:66\u201373.","journal-title":"Thromb Haemost"},{"key":"397_CR7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/ard.2003.006163","volume":"62","author":"GR Hughes","year":"2003","unstructured":"Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis. 2003;62:1127.","journal-title":"Ann Rheum Dis"},{"key":"397_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","volume":"10","author":"D Nochy","year":"1999","unstructured":"\u2022 Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999;10:507\u201318. Relevant description of intrarenal APS lesions.","journal-title":"J Am Soc Nephrol"},{"key":"397_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","volume":"6","author":"F Garcia-Martin","year":"1991","unstructured":"Garcia-Martin F, De Arriba G, Carrascosa T, et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant. 1991;6:543\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"397_CR10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.00460110","volume":"5","author":"RA Sinico","year":"2010","unstructured":"Sinico RA, Cavazzana I, Nuzzo M, et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol. 2010;5:1211\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 6","key":"397_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ndt\/16.suppl_6.60","volume":"16","author":"PG Vlachoyiannopoulos","year":"2001","unstructured":"Vlachoyiannopoulos PG, Kanellopoulos P, Tektonidou M, Moutsopoulos HM. Renal involvement in antiphospholipid syndrome. Nephrol Dial Transplant. 2001;16 Suppl 6:60\u20132.","journal-title":"Nephrol Dial Transplant"},{"key":"397_CR12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019\u201327.","journal-title":"Arthritis Rheum"},{"key":"397_CR13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou MG, Sotsiou F, Nakopoulou L, et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum. 2004;50:2569\u201379.","journal-title":"Arthritis Rheum"},{"key":"397_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","volume":"13","author":"E Daugas","year":"2002","unstructured":"Daugas E, Nochy D, Huong DL, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol. 2002;13:42\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"397_CR15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1440-1797.2007.00792.x","volume":"12","author":"B Cheunsuchon","year":"2007","unstructured":"Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, et al. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton). 2007;12:474\u201380.","journal-title":"Nephrology (Carlton)"},{"key":"397_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reuma.2008.12.011","volume":"5","author":"JM Miranda","year":"2009","unstructured":"Miranda JM, Jara LJ, Calleja C, et al. Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE). Reumatol Clin. 2009;5:209\u201313.","journal-title":"Reumatol Clin"},{"key":"397_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0961203310397410","volume":"20","author":"R Silvari\u00f1o","year":"2011","unstructured":"Silvari\u00f1o R, Sant F, Espinosa G, et al. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus. 2011;20:721\u20139.","journal-title":"Lupus"},{"key":"397_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","volume":"32","author":"R Cervera","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plasin MA, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d. J Autoimmun. 2009;32:240\u20135.","journal-title":"J Autoimmun"},{"key":"397_CR19","first-page":"1413","volume":"18","author":"RA Asherson","year":"1991","unstructured":"Asherson RA, Noble GE, Hughes GR. Hypertension, renal artery stenosis and the \u201cprimary\u201d antiphospholipid syndrome. J Rheumatol. 1991;18:1413\u20135.","journal-title":"J Rheumatol"},{"key":"397_CR20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","volume":"62","author":"SR Sangle","year":"2003","unstructured":"Sangle SR, D\u2019Cruz DP, Jan W, et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis. 2003;62:999\u20131002.","journal-title":"Ann Rheum Dis"},{"key":"397_CR21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1191\/0961203303lu493ed","volume":"12","author":"SR Sangle","year":"2003","unstructured":"Sangle SR, D\u2019Cruz DP. Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus. 2003;12:803\u20134.","journal-title":"Lupus"},{"key":"397_CR22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/096120339700600701","volume":"6","author":"J George","year":"1997","unstructured":"George J, Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus. 1997;6:559\u201360.","journal-title":"Lupus"},{"key":"397_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/qjmed\/92.1.57","volume":"92","author":"D Harats","year":"1999","unstructured":"Harats D, George J, Levy Y, et al. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. QJM. 1999;92:57\u20139.","journal-title":"QJM"},{"key":"397_CR24","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/ndt\/13.10.2645","volume":"13","author":"R Rysava","year":"1998","unstructured":"Rysava R, Zabka J, Peregrin JH, et al. Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant. 1998;13:2645\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"397_CR25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/rheumatology\/keg248","volume":"42","author":"J Delgado Alves","year":"2003","unstructured":"Delgado Alves J, Kumar S, Isenberg DA. Cross-reactivity between anticardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford). 2003;42:893\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"397_CR26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","volume":"341","author":"O Vaarala","year":"1993","unstructured":"Vaarala O, Alfthan G, Jauhiainen M, et al. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet. 1993;341:923\u20135.","journal-title":"Lancet"},{"key":"397_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-008-8112-z","volume":"36","author":"MG Tektonidou","year":"2009","unstructured":"\u2022 Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol. 2009;36:131\u201340. Comprehensive description of APS nephropathy.","journal-title":"Clin Rev Allergy Immunol"},{"key":"397_CR28","first-page":"465","volume":"11","author":"RA Asherson","year":"1993","unstructured":"Asherson RA, Khamashta MA, Hughes GR. Hypertension and the antiphospholipid antibodies. Clin Exp Rheumatol. 1993;11:465\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"397_CR29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/ard.56.9.562","volume":"56","author":"NS Lai","year":"1997","unstructured":"Lai NS, Lan JL. Renal vein thrombosis in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis. 1997;56:562\u20134.","journal-title":"Ann Rheum Dis"},{"key":"397_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/0961203305lu2058oa","volume":"14","author":"DP D\u2019Cruz","year":"2005","unstructured":"D\u2019Cruz DP. Renal manifestations of the antiphospholipid syndrome. Lupus. 2005;14:45\u20138.","journal-title":"Lupus"},{"key":"397_CR31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000235941","volume":"30","author":"A Gigante","year":"2009","unstructured":"Gigante A, Gasperini ML, Cianci R, et al. Antiphospholipid antibodies and renal involvement. Am J Nephrol. 2009;30:405\u201312.","journal-title":"Am J Nephrol"},{"key":"397_CR32","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/ndt\/gfq356","volume":"25","author":"B Alchi","year":"2010","unstructured":"Alchi B, Griffiths M, Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant. 2010;25:3147\u201354.","journal-title":"Nephrol Dial Transplant"},{"key":"397_CR33","first-page":"1983","volume":"35","author":"MG Tektonidou","year":"2008","unstructured":"Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol. 2008;35:1983\u20138.","journal-title":"J Rheumatol"},{"key":"397_CR34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","volume":"9","author":"GR Hughes","year":"1984","unstructured":"Hughes GR. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol. 1984;9:535\u201344.","journal-title":"Clin Exp Dermatol"},{"key":"397_CR35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11926-009-0008-2","volume":"11","author":"D D\u2019Cruz","year":"2009","unstructured":"D\u2019Cruz D. Renal manifestations of the antiphospholipid syndrome. Curr Rheumatol Rep. 2009;11:52\u201360.","journal-title":"Curr Rheumatol Rep"},{"key":"397_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/qjmed\/93.2.127","volume":"93","author":"T Godfrey","year":"2000","unstructured":"Godfrey T, Khamashta MA, Hughes GR. Antiphospholipid syndrome and renal artery stenosis. QJM. 2000;93:127\u20139.","journal-title":"QJM"},{"key":"397_CR37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.51.10.1180-b","volume":"51","author":"E Rossi","year":"1992","unstructured":"Rossi E, Sani C, Zini M, et al. Anticardiolipin antibodies and renovascular hypertension. Ann Rheum Dis. 1992;51:1180\u20131.","journal-title":"Ann Rheum Dis"},{"key":"397_CR38","first-page":"2817","volume":"27","author":"D Erkan","year":"2000","unstructured":"Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol. 2000;27:2817\u201321.","journal-title":"J Rheumatol"},{"key":"397_CR39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/rheumatology\/keg302","volume":"42","author":"NA Dayal","year":"2003","unstructured":"Dayal NA, Isenberg DA. Endstage renal failure in primary antiphospholipid syndrome\u2014case report and review of literature. Rheumatology (Oxford). 2003;42:1128\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"397_CR40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","volume":"23","author":"LN Prieto","year":"1994","unstructured":"Prieto LN, Suki WN. Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am J Kidney Dis. 1994;23:587\u201390.","journal-title":"Am J Kidney Dis"},{"key":"397_CR41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","volume":"48","author":"P Brunet","year":"1995","unstructured":"Brunet P, Aillaud MF, San Marco M, et al. Antiphospholipids in hemodi\u00e1lisis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int. 1995;48:794\u2013800.","journal-title":"Kidney Int"},{"key":"397_CR42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bmj.300.6741.1696","volume":"300","author":"C Gronhagen-Riska","year":"1990","unstructured":"Gronhagen-Riska C, Teppo AM, Helantera A, et al. Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. BMJ. 1990;300:1696\u20137.","journal-title":"BMJ"},{"key":"397_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01698134","volume":"65","author":"T Sitter","year":"1992","unstructured":"Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol. 1992;65:79\u201382.","journal-title":"Ann Hematol"},{"key":"397_CR44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0049-3848(93)90212-7","volume":"72","author":"J Matsuda","year":"1993","unstructured":"Matsuda J, Saitoh N, Gohchi K, et al. beta 2-Glycoprotein I-dependent andindependent anticardiolipin antibody in patients with end-stage renal disease. Thromb Res. 1993;72:109\u201317.","journal-title":"Thromb Res"},{"key":"397_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","volume":"68","author":"DR Fastenau","year":"1999","unstructured":"Fastenau DR, Wagenknecht DR, McIntyre JA. Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients. Ann Thorac Surg. 1999;68:137\u201342.","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 2","key":"397_CR46","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1177\/096120339800700213","volume":"7","author":"AE Gharavi","year":"1998","unstructured":"Gharavi AE, Pierangeli SS. Origin of antiphospholipid antibodies: induction of aPL by viral peptides. Lupus. 1998;7 Suppl 2:S52\u20134.","journal-title":"Lupus"},{"key":"397_CR47","first-page":"193","volume":"72","author":"S Ozmen","year":"2009","unstructured":"Ozmen S, Danis R, Akin D, Batun S. Anticardiolipin antibodies in hemodyalisis patients with hepatitis C and their role in fistula failure. Clin Nephrol. 2009;72:193\u20138.","journal-title":"Clin Nephrol"},{"key":"397_CR48","first-page":"26","volume":"9","author":"J Roozbeh","year":"2006","unstructured":"Roozbeh J, Serati AR, Malekhoseini SA. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients. Arch Iran Med. 2006;9:26\u201332.","journal-title":"Arch Iran Med"},{"key":"397_CR49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","volume":"34","author":"JH Stone","year":"1999","unstructured":"Stone JH, Amend WJ, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis. 1999;34:1040\u20137.","journal-title":"Am J Kidney Dis"},{"key":"397_CR50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","volume":"12","author":"S Vaidya","year":"1998","unstructured":"Vaidya S, Wang CC, Gugliuzza C, Fish JC. Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies. Clin Transplant. 1998;12:439\u201344.","journal-title":"Clin Transplant"},{"key":"397_CR51","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","volume":"295","author":"W Lim","year":"2006","unstructured":"Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006;295:1050\u20137.","journal-title":"JAMA"},{"key":"397_CR52","first-page":"215","volume":"14","author":"G Tsagalis","year":"2010","unstructured":"Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A. Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia. 2010;14:215\u20136.","journal-title":"Hippokratia"},{"key":"397_CR53","unstructured":"Domingues V, Dadhania D, Hartona C, Pastore R, Erkan D. Hospital for Special Surgery\u2014Cornell protocol for antiphospholipid antibody positive patients undergoing renal transplantation. 14th International Congress on Antiphospholipid Antibodies. Rio de Janeiro, 2013."},{"key":"397_CR54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1253\/jcj.64.541","volume":"64","author":"K Aizawa","year":"2000","unstructured":"Aizawa K, Nakamura T, Sumino H, et al. Renovascular hypertension observed in a patient with antiphospholipid\u2013antibody syndrome. Jpn Circ J. 2000;64:541\u20133.","journal-title":"Jpn Circ J"},{"key":"397_CR55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/art.37759","volume":"65","author":"D Erkan","year":"2013","unstructured":"Erkan D, Vega J, Ramon G, et al. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013;65:464\u201371.","journal-title":"Arthritis Rheum"},{"key":"397_CR56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0961203310395051","volume":"20","author":"R Cervera","year":"2011","unstructured":"\u2022\u2022 Cervera R, Tektonidou MG, Espinosa G, et al. Task force on Catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011;20:165\u201373. Recommendations for the diagnosis and management of APS nephropathy from a task force of APS experts.","journal-title":"Lupus"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0397-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0397-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:22:42Z","timestamp":1746087762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0397-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0397-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2013,12,20]]},"article-number":"397"}}